Fda articles
-
This Week at FDA: FDA's final LDT rule nears, Cardinal Health warning letter, and more
Welcome to another installment of This Week at FDA, your weekly source for updates @ big and small @ on FDA, drug, and medical device regulation, and what we@re reading from around the web. This week, we learned that FDA@s final rule on laboratory developed tests (LDTs) may soon see the light of day. @
-
FDA Warns About Fake Botox
A warning from the U.S. Food and Drug Administration about dangerous counterfeit versions of Botox.
-
FDA testing finds no Bird Flu in diary products
The Bird Flu threat may be easing up on U.S. diary products.